• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Jan 9;21(1):39.
doi: 10.1186/s12879-020-05717-w.
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study


Jon Gitz Holler[SUP] 1 [/SUP], Robert Eriksson[SUP] 2 3 [/SUP], Tomas ?stergaard Jensen[SUP] 2 [/SUP], Maarten van Wijhe[SUP] 2 4 [/SUP], Thea K?lsen Fischer[SUP] 2 5 [/SUP], Ole Schmeltz S?gaard[SUP] 6 [/SUP], Simone Bastrup Israelsen[SUP] 7 [/SUP], Rajesh Mohey[SUP] 8 [/SUP], Thilde Fabricius[SUP] 9 [/SUP], Frederik J?hnk[SUP] 10 [/SUP], Lothar Wiese[SUP] 11 [/SUP], Stine Johnsen[SUP] 12 [/SUP], Christian S?borg[SUP] 13 [/SUP], Henrik Nielsen[SUP] 14 [/SUP], Ole Kirk[SUP] 15 [/SUP], Birgitte Lindegaard Madsen[SUP] 2 16 [/SUP], Zitta Barrella Harboe[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease coronavirus disease 2019 (COVID-19), is a worldwide emergency. Demographic, comorbidity and laboratory determinants of death and of ICU admission were explored in all Danish hospitalised patients.
Methods: National health registries were used to identify all hospitalized patients with a COVID-19 diagnosis. We obtained demographics, Charlson Comorbidity Index (CCI), and laboratory results on admission and explored prognostic factors for death using multivariate Cox proportional hazard regression and competing risk survival analysis.
Results: Among 2431 hospitalised patients with COVID-19 between February 27 and July 8 (median age 69 years [IQR 53-80], 54.1% males), 359 (14.8%) needed admission to an intensive care unit (ICU) and 455 (18.7%) died within 30 days of follow-up. The seven-day cumulative incidence of ICU admission was lower for females (7.9%) than for males (16.7%), (p < 0.001). Age, high CCI, elevated C-reactive protein (CRP), ferritin, D-dimer, lactate dehydrogenase (LDH), urea, creatinine, lymphopenia, neutrophilia and thrombocytopenia within ?24-h of admission were independently associated with death within the first week in the multivariate analysis. Conditional upon surviving the first week, male sex, age, high CCI, elevated CRP, LDH, creatinine, urea and neutrophil count were independently associated with death within 30 days. Males presented with more pronounced laboratory abnormalities on admission.
Conclusions: Advanced age, male sex, comorbidity, higher levels of systemic inflammation and cell-turnover were independent factors for mortality. Age was the strongest predictor for death, moderate to high level of comorbidity were associated with a nearly two-fold increase in mortality. Mortality was significantly higher in males after surviving the first week.

Keywords: COVID-19; Epidemiology; Intensive care unit; Mortality; Nationwide; Prognostic factors; SARS-CoV-2.
 
Back
Top Bottom